Prior authorization has long been one of the more frustrating parts of navigating Medicare Advantage, with beneficiaries often waiting anxiously to find out whether a needed procedure or medication will actually be approved before they can get care. A significant set of federal rule changes taking effect this year is reshaping how quickly these decisions have to be made and how transparent insurers have to be about the process, and understanding what’s actually changed can help you navigate a denial or delay much more effectively if one comes up.
The New Federal Timelines Insurers Must Follow
Starting January 1, 2026, a CMS final rule known as CMS-0057-F put concrete response deadlines in place for Medicare Advantage prior authorization decisions, a requirement that didn’t exist in this specific form previously. Under the new rule, plans must respond to expedited prior authorization requests within 72 hours and standard prior authorization requests within 7 calendar days, timelines designed specifically to address the long-standing complaint that patients were left waiting too long for approvals on procedures, scans, and treatments. This matters practically because a delayed decision on a time-sensitive procedure can mean a worsening condition or a missed treatment window, and having an enforceable deadline gives beneficiaries and their doctors a concrete point at which they can push back if a decision is taking longer than it should.
Alongside the faster timelines, the new rule also requires plans to explain exactly why they deny a request, which is a meaningful shift from a system where denials often arrived with vague or minimal explanation, leaving patients and doctors guessing about what additional documentation might change the outcome. This transparency requirement is specifically designed to make the appeals process more effective, since knowing the precise reason for a denial allows your doctor to address that specific gap directly rather than resubmitting the same request and hoping for a different result. If you receive a denial that doesn’t clearly explain the reasoning, it’s worth explicitly requesting that clarification in writing, since the new rule gives you a stronger basis to expect a specific answer rather than a generic rejection notice.
New Protections Around Continuity of Care
One of the more practical protections built into this year’s rule changes addresses a specific problem that used to catch a lot of people off guard: mid-treatment authorization resets. Previously, a beneficiary already approved for an ongoing course of treatment could sometimes find that authorization interrupted if their provider left the plan’s network or if they switched plans partway through treatment, forcing a restart of the approval process at an inconvenient and potentially harmful moment. The new continuity of care protections are designed specifically to prevent this kind of disruptive reset, meaning an authorization that’s already in place for an ongoing treatment plan should generally continue through the course of that treatment rather than being interrupted by an administrative change unrelated to your actual medical need.
This protection matters most for beneficiaries in the middle of extended treatment courses, such as chemotherapy or physical therapy following a major procedure, where an interruption isn’t just inconvenient but can meaningfully affect the treatment’s effectiveness. If you’re in an ongoing treatment course and your provider situation or plan changes, it’s worth proactively confirming with your plan that your existing authorization will carry forward, rather than waiting to discover a gap only when a scheduled appointment gets denied unexpectedly.
What’s Different for Original Medicare This Year
Historically, prior authorization has been almost exclusively a Medicare Advantage phenomenon, with 99% of Medicare Advantage enrollees required to get prior authorization for at least some services, usually more expensive services like inpatient hospital stays and chemotherapy, while Original Medicare largely operated without this requirement. That’s shifted for a subset of beneficiaries this year through a new pilot program called the WISeR Model, which requires prior authorization for 17 specific procedures in six states: Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington. If you have Original Medicare and live in one of these states, it’s worth checking whether any procedure you’re considering falls on this list before scheduling, since an unexpected prior authorization requirement on a service you assumed would be automatically covered under traditional Medicare could otherwise catch you off guard.
If you have Original Medicare paired with a Medigap supplemental policy, it’s worth understanding that Medigap plans supplement Original Medicare and do not use prior authorization themselves; these new rules apply specifically to Medicare Advantage plans, though the WISeR pilot’s prior authorization requirement still applies to the underlying Original Medicare coverage regardless of whether you carry a Medigap policy alongside it. This distinction is worth clarifying directly with your plan if you’re unsure how the pilot program applies to your specific situation, particularly if you live in one of the six affected states and have an upcoming procedure that might fall under this new requirement.
Provider “Gold Carding” and What It Means for You
Another feature of this year’s changes worth understanding is a mechanism sometimes referred to as gold carding, which exempts high-performing providers with strong approval track records from certain prior authorization requirements going forward. The logic behind this approach is that providers who consistently submit requests that get approved, rather than denied or sent back for additional documentation, have demonstrated a pattern that doesn’t require the same level of scrutiny going forward, and exempting them from repeat authorization steps reduces administrative burden without compromising the program’s original cost-control goals. For beneficiaries, this can mean a smoother, faster path to certain approvals if your specific provider has earned this status, since a gold-carded provider’s requests may bypass some of the standard review steps that would otherwise apply.
This is worth asking your provider’s office about directly, since gold card status varies by provider and by specific service category, and providers themselves are often aware of their own standing in this system even if patients aren’t. If your regular specialist has earned this status for the type of care you need, it’s a good sign that your authorization process for that specific service should move more smoothly than it might have in previous years.
What to Do If You’re Still Facing a Delay or Denial
Even with these new timelines and transparency requirements in place, prior authorization delays and denials haven’t disappeared entirely, and it’s worth knowing what to do if you find yourself facing one despite these protections. If a standard request has exceeded the 7-day window or an expedited request has exceeded 72 hours without a decision, that delay itself is now a concrete violation you can point to directly when escalating the issue with your plan, rather than an ambiguous complaint about slow service. Documenting the date your request was submitted and the specific timeline that applies to your situation gives you a much stronger position when calling your plan’s member services line to push for a faster resolution.
If you receive a denial, the new transparency requirements mean you’re entitled to a clear explanation of the specific reasoning, and requesting that explanation in writing, then sharing it directly with your doctor, is the most effective way to determine whether an appeal with additional documentation is likely to succeed. Understanding these updated rules before you actually need to use them puts you in a considerably stronger position than discovering them for the first time in the middle of a stressful denial, and if your current plan’s prior authorization track record has been a recurring source of frustration, comparing it against other Medicare Advantage plans during your next enrollment window is a reasonable next step to consider.
